An observational study in Mammary Ductal Carcinoma, sponsored by Turku University Hospital. Status unknown at 1 site in Finland. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-12-02.
Sponsored by Turku University Hospital · Observational
The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.
151 studies on the registry are indexed under Carcinoma, Ductal; 17 are open to participants now.
This study's planned enrollment of 100 is above the median of 88 across 26 observational studies indexed under Carcinoma, Ductal.
Browse Carcinoma, Ductal studies →Turku University Hospital is the lead sponsor of 280 studies on the registry; 65 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Newly diagnosted breast cancer patients
Exclusion Criteria:
This study is status unknown, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Turku University Hospital